Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2010 - 2026)

Jazz Pharmaceuticals has reported Prepaid Assets for 17 years, with the latest figure at $285.3 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 9.81% year-over-year to $285.3 million; the trailing twelve-month figure through Mar 2026 stood at $285.3 million (up 9.81% YoY), and the FY2025 full-year result was $323.9 million, up 23.84% from the prior year.
• Prepaid Assets for Q1 2026 stood at $285.3 million, down from $323.9 million in the prior quarter.
• The five-year high for Prepaid Assets was $323.9 million in Q4 2025, with the low at $91.9 million in Q4 2022.
• Average Prepaid Assets over 5 years is $215.0 million, with a median of $245.2 million recorded in 2023.
• Year-over-year, Prepaid Assets slumped 63.58% in 2022 and jumped 249.04% in 2023.
• Tracing JAZZ's Prepaid Assets over 5 years: stood at $91.9 million in 2022, then jumped by 249.04% to $320.8 million in 2023, then retreated by 18.47% to $261.5 million in 2024, then increased by 23.84% to $323.9 million in 2025, then retreated by 11.92% to $285.3 million in 2026.
• The last three Prepaid Assets figures came in at $285.3 million (Q1 2026), $323.9 million (Q4 2025), and $315.4 million (Q3 2025), per Business Quant data.

Peer Comparison